In an era defined by rapid technological advancements, artificial intelligence (AI) has emerged as a transformative force for the PLS sector in reshaping research, diagnostics and patient care
FinTech BizNews Service
Mumbai, September 6, 2024: To understand how GCCs in the PLS (pharma and life sciences) industry are adopting GenAI, PwC, in collaboration with National Association of Software and Service Companies (nasscom), conducted multiple comprehensive roundtables and one-on-one interviews between November 2023 and January 2024, eliciting point of views and responses from leaders and decision makers of GCCs of a few global firms which are operating out of India, that are also nasscom members. The primary objective of this study was to understand the awareness, adoption and impact of GenAI across the PLS sectors.
In an era defined by rapid technological advancements, artificial intelligence (AI) has emerged as a transformative force for the PLS sector in reshaping research, diagnostics and patient care. The role of global capability centres (GCCs) is increasingly becoming important due to the unprecedented changes in the pharma industry in the last decade. These centres – which are strategically established by organizations to harness global talent and expertise – are evolving into innovation hubs for the PLS sector. In recent years, generative AI (GenAI) has emerged as a powerful tool which offers novel capabilities in areas such as data analysis, pattern recognition and knowledge synthesis.
Click to read further: https://community.nasscom.in/communities/data-science-ai-community/generative-ai-next-frontier-transformation-global-0
